139 related articles for article (PubMed ID: 38246527)
1. Characterizing Immune Infiltration in Esthesioneuroblastoma Subtypes Through Gene Expression Deconvolution.
Batchu S; Gill AS; Karsy M
World Neurosurg; 2024 Mar; 183():e928-e935. PubMed ID: 38246527
[TBL] [Abstract][Full Text] [Related]
2. Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny.
Classe M; Yao H; Mouawad R; Creighton CJ; Burgess A; Allanic F; Wassef M; Leroy X; Verillaud B; Mortuaire G; Bielle F; Le Tourneau C; Kurtz JE; Khayat D; Su X; Malouf GG
Cell Rep; 2018 Oct; 25(3):811-821.e5. PubMed ID: 30332658
[TBL] [Abstract][Full Text] [Related]
3. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
[TBL] [Abstract][Full Text] [Related]
5. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
6. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
7. Regional Recurrences and Hyams Grade in Esthesioneuroblastoma.
Ziai H; Yu E; Weinreb I; Perez-Ordonez B; Yao CMKL; Xu W; Yang D; Witterick IJ; Monteiro E; Gilbert RW; Irish JC; Gullane PJ; Goldstein DP; Ringash J; Bayley A; de Almeida JR
J Neurol Surg B Skull Base; 2021 Dec; 82(6):608-614. PubMed ID: 34745827
[No Abstract] [Full Text] [Related]
8. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
9. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.
Van Gompel JJ; Giannini C; Olsen KD; Moore E; Piccirilli M; Foote RL; Buckner JC; Link MJ
J Neurol Surg B Skull Base; 2012 Oct; 73(5):331-6. PubMed ID: 24083125
[TBL] [Abstract][Full Text] [Related]
11. CD20
Sato J; Kitano S; Motoi N; Ino Y; Yamamoto N; Watanabe S; Ohe Y; Hiraoka N
Cancer Sci; 2020 Jun; 111(6):1921-1932. PubMed ID: 32277550
[TBL] [Abstract][Full Text] [Related]
12. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
[TBL] [Abstract][Full Text] [Related]
13. Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study.
Vuong HG; Nguyen DD; El-Rassi E; Ngo TNM; Dunn IF
World Neurosurg; 2022 Jan; 157():e245-e253. PubMed ID: 34628034
[TBL] [Abstract][Full Text] [Related]
14. An atypical Esthesioneuroblastoma of the sphenoid sinus: a case report.
Touihmi S; Horrane I; Rkain I
Ann Med Surg (Lond); 2023 May; 85(5):2029-2033. PubMed ID: 37228980
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.
Feng L; Fang J; Zhang L; Li H; Zhou B; Chen X; Li Y; Han D
Clin Neurol Neurosurg; 2015 Nov; 138():94-8. PubMed ID: 26310690
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Immune Infiltration in HNC and Their Clinical Implications: A Gene Expression-Based Study.
Song J; Deng Z; Su J; Yuan D; Liu J; Zhu J
Front Oncol; 2019; 9():1285. PubMed ID: 31867268
[No Abstract] [Full Text] [Related]
17. Clinicopathological features and prognostic significance of programmed death ligand 1 in pediatric ALK-positive anaplastic large cell lymphoma: results of the ALCL99 treatment in Japan.
Iwafuchi H; Nakazawa A; Sekimizu M; Mori T; Osumi T; Iijima-Yamashita Y; Ohki K; Kiyokawa N; Fukano R; Saito AM; Horibe K; Kobayashi R;
Hum Pathol; 2021 Oct; 116():112-121. PubMed ID: 34363798
[TBL] [Abstract][Full Text] [Related]
18. Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature.
Wu K; Avila SA; Bhuyan R; Matloob A; Del Signore AG; Hadjipanayis C; Chelnis J
Orbit; 2022 Feb; 41(1):1-14. PubMed ID: 33317383
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China.
Yuan Y; Ye J; Qiu H; Niu S; Wen B; Wang D; Cao X; Ren Y
J Cancer; 2018; 9(1):174-181. PubMed ID: 29290783
[No Abstract] [Full Text] [Related]
20. Immunohistochemical Profiling and Staging in Esthesioneuroblastoma: A Single-Center Cohort Study and Systematic Review.
Henson JC; Cutler CC; Cole KL; Lucke-Wold B; Khan M; Alt JA; Karsy M
World Neurosurg; 2023 Feb; 170():e652-e665. PubMed ID: 36435382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
